Table 1 MICs of antimicrobial agents for isolates from multiple body site, mCIM/eCIM interpretations and PCR results
Antimicrobials | Samples | ||||
|---|---|---|---|---|---|
BC-1 | BC-2 | BC-3 | K-1 | K-2 | |
Amikacin (µg/ml) |  ≤ 16 (S) |  ≤ 16 (S) |  ≤ 16 (S) |  ≤ 16 (S) |  ≤ 16 (S) |
Aztreonam (µg/ml) |  ≤ 4 (S) |  ≤ 4 (S) |  > 16 (R) |  > 16 (R) |  > 16 (R) |
Cefepime (µg/ml) |  ≤ 2 (S) |  ≤ 2 (S) | 8 (SDD) |  > 16 (R) |  > 16 (R) |
Cefotaxime (µg/ml) | 8 (R) |  ≤ 2 (S) |  > 32 (R) |  > 32 (R) |  > 32 (R) |
Ceftazidime (µg/ml) | 4 (S) | 4 (S) | 16 (R) |  > 16 (R) | 16 (R) |
Ceftazidime/Avibactam (µg/ml) |  ≤ 4 (S) |  ≤ 4 (S) |  ≤ 4 (S) |  ≤ 4 (S) |  ≤ 4 (S) |
Ceftolozane/Tazobactam (µg/ml) |  ≤ 2 (S) |  ≤ 2 (S) | 8 (R) | 8 (R) | 8 (R) |
Ceftriaxone (µg/ml) | 8 (R) | 2 (I) | 8 (R) |  > 32 (R) |  > 32 (R) |
Ciprofloxacin (µg/ml) | 1 (R) | 1 (R) |  > 2 (R) |  > 2 (R) |  > 2 (R) |
Ertapenem (µg/ml) |  ≤ 0.5 (S) |  ≤ 0.5 (S) | 1 (I) | 1 (I) |  ≤ 0.5 (S) |
Gentamicin (µg/ml) |  ≤ 2 (S) |  ≤ 2 (S) | 8 (I) |  > 8 (R) | 4 (S) |
Imipenem (µg/ml) | 2 (I) | 2 (I) | 2 (I) | 2 (I) | 2 (I) |
Levofloxacin (µg/ml) |  ≤ 0.5 (S) |  ≤ 0.5 (S) |  > 4 (R) |  > 4 (R) |  > 4 (R) |
Meropenem (µg/ml) |  ≤ 1 (S) |  ≤ 1 (S) |  ≤ 1 (S) |  ≤ 1 (S) |  ≤ 1 (S) |
Meropenem/Vaborbactam (µg/ml) |  ≤ 2 (S) |  ≤ 2 (S) |  ≤ 2 (S) |  ≤ 2 (S) |  ≤ 2 (S) |
Moxifloxacin (µg/ml) |  ≤ 2 (S) |  ≤ 2 (S) |  > 4 (R) |  > 4 (R) |  > 4 (R) |
Piperacillin/Tazobactam (µg/ml) |  ≤ 8 (S) |  ≤ 8 (S) | 32 (R) | 64 (R) | 64 (R) |
Tobramycin (µg/ml) |  ≤ 2 (S) |  ≤ 2 (S) | 8 (I) |  > 8 (R) | 8 (I) |
mCIM/eCIM interpretation | Serine carbapenemase detected | Serine carbapenemase detected | Serine carbapenemase detected | Serine carbapenemase detected | Serine carbapenemase detected |
Carbapenemase gene detected a | blaKPC | blaKPC | blaKPC | blaKPC | blaKPC |